Lived Experiences of Women Diagnosed With HPV Infection
Living Between Fear and Uncertainty: The Lived Experiences of Women Diagnosed With HPV Infection - A Phenomenological Study
This qualitative phenomenological study aims to explore the lived experiences of women diagnosed with human papillomavirus (HPV) infection. The study will examine women's emotional responses to the diagnosis, its perceived effects on daily life, sexual life and partner relationships, their experiences of disclosing the diagnosis, and their information and support needs. Eligible women diagnosed with HPV infection will participate in individual semi-structured interviews. The interview data will be analyzed thematically to identify common themes reflecting participants' experiences and perceptions.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This study is designed as a qualitative phenomenological study to gain an in-depth understanding of the lived experiences of women diagnosed with HPV infection. Participants will be adult women with a confirmed HPV diagnosis who meet the eligibility criteria and provide written informed consent.
Data will be collected through individual face-to-face semi-structured interviews. The interview guide explores participants' experiences from the time of HPV diagnosis, emotional responses, perceived effects on daily and sexual life, partner relationships and disclosure experiences, concerns regarding future health, experiences with healthcare professionals, and perceived information and support needs. Interviews are expected to last approximately 30-45 minutes and will be audio-recorded with participants' permission.
Data collection will continue until data saturation is achieved, with approximately 15-20 participants anticipated. Interview recordings will be transcribed and analyzed thematically. Participant identities will be protected through coding, and personally identifying information will not be included in the analysis or reporting of the findings.
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studiekontakt
- Namn: Ahmet Demirci, MD
- Telefonnummer: +905418807091
- E-post: ahmet.demirci@bilecik.edu.tr
Studieorter
-
-
Bilecik
-
Bilecik, Bilecik, Turkiet (Türkiye), 11230
- Rekrytering
- Bilecik Training and Research Hospital
-
Underutredare:
- Aysun Acun, PhD
-
Kontakt:
- Ahmet Demirci, MD
- Telefonnummer: +905418807091
- E-post: ahmet.demirci@bilecik.edu.tr
-
Underutredare:
- Büşra Küçüktürkmen, PhD
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Adult women aged 18 years or older with a confirmed HPV infection who meet the eligibility criteria and voluntarily agree to participate in the study. Participants will be recruited among women evaluated at the study center and will undergo individual semi-structured interviews regarding their lived experiences following HPV diagnosis.
Beskrivning
Inclusion Criteria:
- Confirmed diagnosis of HPV infection by HPV DNA testing
- Ability to communicate verbally in Turkish
- Willingness to participate in an individual semi-structured interview
- Provision of written informed consent
Exclusion Criteria:
- Inability to communicate adequately in Turkish
- Cognitive or communication difficulties that would prevent participation in the interview
- Refusal or withdrawal of informed consent
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: OTHER
- Tidsperspektiv: PROSPECTIVE
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Women Diagnosed With HPV Infection
Adult women aged 18 years or older with a confirmed HPV infection who meet the eligibility criteria and provide written informed consent. Participants will take part in individual semi-structured interviews exploring their lived experiences following HPV diagnosis. |
Participants will take part in an individual face-to-face semi-structured interview exploring their lived experiences following HPV diagnosis, including emotional responses, daily and sexual life, partner relationships, disclosure experiences, future health concerns, experiences with healthcare professionals, and information and support needs. Interviews are expected to last approximately 30-45 minutes and will be audio-recorded with participants' permission. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Lived Experiences of Women Diagnosed With HPV Infection
Tidsram: At least 4 weeks after HPV diagnosis, following the initial acute adjustment period, during a single 30-45-minute semi-structured interview.
|
Participants' lived experiences following HPV diagnosis will be explored through individual semi-structured interviews. Interview transcripts will be analyzed thematically to identify themes related to emotional responses, daily and sexual life, partner relationships, disclosure experiences, future health concerns, interactions with healthcare professionals, and information and support needs. |
At least 4 weeks after HPV diagnosis, following the initial acute adjustment period, during a single 30-45-minute semi-structured interview.
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Ahmet Demirci, Bilecik Seyh Edebali University Faculty of Medicine
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
- Urogenitala sjukdomar
- Genitala sjukdomar
- Patologiska processer
- Sjukdomsegenskaper
- Infektioner
- Virussjukdomar
- Smittsamma sjukdomar
- Sexuellt överförbara sjukdomar, virala
- Sexuellt överförbara sjukdomar
- DNA-virusinfektioner
- Tumörvirusinfektioner
- Patologiska tillstånd, tecken och symtom
- Papillomavirusinfektioner
Andra studie-ID-nummer
- HPV-PHEN-2026-01
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Individual participant data will not be publicly shared due to the qualitative nature of the study and the potential risk of identifying participants from interview data. Data will be kept confidential and used only for the purposes of this study.
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .